Research / NVT / Fundamental state Inspectable configuration
State dimensions Filing 0001720635-21-000046 General Corporate
Debt relative to revenue 54th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.debt_to_revenue
180.26% · OPTIONAL · VALID
Capex intensity 15th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.33% · OPTIONAL · VALID
Operating cash generation 62th Own-history percentile · N=13
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
15.53% · OPTIONAL · VALID
Share-count growth 67th Own-history percentile · N=9
Evidence method Yoy · gp.fundamentals.shares_outstanding
-1.07% · CORE · VALID
Revenue growth 100th Own-history percentile · N=9
Evidence method Yoy · gp.fundamentals.revenue
34.46% · CORE · VALID
Inventory pressure 62th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
45.80% · OPTIONAL · VALID
Gross margin 54th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.gross_margin
39.12% · CORE · VALID
Operating margin 69th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.operating_margin
14.68% · CORE · VALID
R&D intensity 0th Own-history percentile · N=13
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.95% · OPTIONAL · VALID
SBC intensity 100th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
1.06% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 34 states Self-history eligible
Sep 30, 2021 10/10 normalized Level 3 Dec 31, 2021 10/10 normalized Level 3 Mar 31, 2022 10/10 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 10/10 normalized Level 3 Mar 31, 2023 10/10 normalized Level 3 Jun 30, 2023 10/10 normalized Level 3 Sep 30, 2023 10/10 normalized Level 3 Dec 31, 2023 10/10 normalized Level 3 Mar 31, 2024 10/10 normalized Level 3 Jun 30, 2024 10/10 normalized Level 3 Sep 30, 2024 10/10 normalized Level 3 Dec 31, 2024 10/10 normalized Level 3 Mar 31, 2025 10/10 normalized Level 3 Jun 30, 2025 10/10 normalized Level 3 Sep 30, 2025 10/10 normalized Level 3 Dec 31, 2025 10/10 normalized Level 3 Mar 31, 2026 10/10 normalized Level 3 Jun 30, 2026 10/10 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 168.19%
Current 180.26%
Delta 12.07% Capex Intensity Decreased
Previous 1.80%
Current 1.33%
Delta -0.47% Cash Generation Increased
Previous 9.09%
Current 15.53%
Delta 6.44% Dilution Increased
Previous -1.28%
Current -1.07%
Delta 0.21% Growth Increased
Previous 5.38%
Current 34.46%
Delta 29.08% Inventory Pressure Increased
Previous 43.34%
Current 45.80%
Delta 2.46% Margin Increased
Previous 38.08%
Current 39.12%
Delta 1.04% Profitability Increased
Previous 14.65%
Current 14.68%
Delta 0.04% R And D Intensity Decreased
Previous 2.08%
Current 1.95%
Delta -0.13% Sbc Intensity Increased
Previous -0.04%
Current 1.06%
Delta 1.10% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.